Business
Celularity and CH Trading Group Announce Product Distribution Agreement with Tamer Group to be the Exclusive Distributor for the Kingdom of Saudi Arabia
Tamer Group will be the exclusive distributor of the Celularity branded biomaterial products in Saudi Arabia, opening access to Celularity's Halal-Certified
About this update from Celularity Inc.
[{"type":"text","content":"Tamer Group will be the exclusive distributor of the Celularity branded biomaterial products in Saudi Arabia, opening access to Celularity's Halal-Certified regenerative biomaterial, health and wellness products \nFLORHAM PARK, N.J, RIYADH, Saudi Arabia and JEDDAH, Saudi Arabia , Jan. 11, 2023 /PRNewswire/ -- Celularity Inc. (NASDAQ: CELU) (\"Celularity\"), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, and CH Trading Group LLC (\"CH Trading Group\"), an international import, export and trading company, today announced that they have entered into an exclusive distribution agreement with the Tamer Group (\"Tamer\"). The Tamer Group, a leading Middle East healthcare distribution company, will be the exclusive distributor for Celularity's branded regenerative biomaterial products in Saudi Arabia.\n\"Celularity's Halal-Certified regenerative biomaterial products enable Tamer to realize our fundamental ambitions of contributing to personal wellness and public health, as well as supporting Saudi Arabia's Vision 2030 plan for healthcare innovation and development,\" said Tamer Group Chairman & Managing Partner, Ayman Tamer.\n\"We are looking forward to partnering with Celularity and CH Group on this exciting opportunity across Saudi Arabia and providing unprecedented access to these cutting-edge therapeutics to all members of the community,\" stated Dr. Yasser Khattab, Tamer Group Healthcare CEO\nAccording to the most recent analysis by Emergent Research, the worldwide regenerative medicine market was US $9.80 billion in 2021, and is anticipated to grow at a revenue compounded annual growth rate of 15.9% to reach US $37.10 billion in 2030.\n\"Saudi Arabia is a prime market for Celularity's commercial regenerative biomaterial products,\" said CEO of CH Trading Group, Sayed Zayan. \"We are excited to partner with Tamer Group and to be a part of fulfilling their commitment to the development of the Kingdom's healthcare sector.\" \nThrough the agreement, CH Trading Group will distribute to more than 100 countries that are members of or associated with the following intergovernmental organizations (\"Islamic Markets\"):\nThe Organization of Islamic Cooperation, which has 57 member countries on four continents;The Gulf Cooperation Council, comprised of Bahrain, Kuwait, Oman,...